Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Susan Halabi

1-50 of 198 results

View this query on the Wikidata Query Service
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

scientific article
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

scientific article (publication date: 6 March 2003)
Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206

scientific article published on 20 October 2008
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

scientific article
Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206

scientific article
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

scientific article published in April 2003
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.

scientific article
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

scientific article published on 10 February 2009
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).

scientific article published in March 2004
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

scientific article
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

scientific article
American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma

scientific article published on 21 May 2007
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.

scientific article
Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

scientific article
Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

scientific article published on 21 January 2014
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.

scientific article
Circulating levels of inflammatory cytokines and risk of colorectal adenomas

scientific article published on January 2008
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

scientific article
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.

scientific article
Pain predicts overall survival in men with metastatic castration-refractory prostate cancer.

scientific article published on May 2008
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group

scientific article
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

scientific article published on 3 June 2015
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).

scientific article published on 03 March 2014
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.

scientific article
Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer

scientific article
Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin.

scientific article published on 13 August 2012
Effects of a mammography decision-making intervention at 12 and 24 months.

scientific article published in May 2002
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival

scientific article published on 11 December 2009
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

scientific article
Validation of a breast cancer risk assessment model in women with a positive family history.

scientific article published in April 1994
Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women

scientific article published on 25 February 2008
Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma

scientific article published in April 2004
Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study

scientific article published in April 2007
American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine

scientific article published on 19 January 2016
Breast cancer screening behaviors and attitudes in three racial/ethnic groups

scientific article published on January 1, 1992
Progression-free survival as a predictor of overall survival in men with castrate-resistant prostate cancer.

scientific article published on 20 April 2009
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

scientific article published on 10 August 2017
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy

scientific article published on 17 October 2013
A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813.

scientific article
Can tailored interventions increase mammography use among HMO women?

scientific article published on 01 January 2000
A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: results from Cancer and Leukemia Group B Study 90006.

scientific article
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.

scientific article published on 15 March 2018
A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer

scientific article
Factors associated with perceived risk of breast cancer among women attending a screening program.

scientific article published in November 1993
Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapy

scientific article published on 07 October 2013
Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study

scientific article published in August 2005
Analgesic drug use and risk of ovarian cancer

scientific article (publication date: 2006)
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality

scientific article published on 01 July 2019
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809

scientific article published on February 14, 2011
Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer.

scientific article published on 11 May 2017

Paulina is supported by:

About Paulina

Help